Skip to main navigation Skip to search Skip to main content

The Journey of an EGFR-Mutant Lung Adenocarcinoma through Erlotinib, Osimertinib and ABCP Immunotherapy Regimens: Sensitivity and Resistance

  • Albina Kibirova
  • , Malcolm D. Mattes
  • , Matthew Smolkin
  • , Patrick C. Ma

Research output: Contribution to journal › Article › peer-review

11   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'The Journey of an EGFR-Mutant Lung Adenocarcinoma through Erlotinib, Osimertinib and ABCP Immunotherapy Regimens: Sensitivity and Resistance'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science